Josef Chudacek
Overview
Explore the profile of Josef Chudacek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
54
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Spicka P, Vanek P, Chudacek J, Falt P, Hruska F, rezac T, et al.
AME Case Rep
. 2024 Oct;
8:90.
PMID: 39380871
Background: This study highlights an unusual and previously unreported adverse event (AE) following the minimally invasive treatment of pancreatic walled-off necrosis (WON). The standard treatment for WON currently involves primary...
2.
Chudacek J, Bohanes T, Szkorupa M, Stasek M, Hanuliak J, Skanderova D, et al.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
. 2024 Mar;
PMID: 38533732
Background: Neurogenic tumors are the third most common tumors occurring within the mediastinum. Predominantly completely asymptomatic, they are most often found in the posterior mediastinum, although they may also be...
3.
Rehulkova A, Chudacek J, Prokopova A, Vidlarova M, Stranska J, Drabek J, et al.
Transl Lung Cancer Res
. 2023 Jun;
12(5):1034-1050.
PMID: 37323172
Background: Surgical treatment of early-stage non-small cell lung cancer (NSCLC) yields highest expectations for recovery. However, the frequency of further disease progression remains high since micro-metastatic disease may be undetected...
4.
Chudacek J, Spicka P, Kolar M, Stasek M, Kolcun S, Klos D, et al.
Antibiotics (Basel)
. 2023 Mar;
12(3).
PMID: 36978393
Background: Diffuse peritonitis is an acute abdominal condition characterized by high mortality. The main treatment modality is surgery, requiring a subsequent prolonged hospital stay. These patients are, among other things,...
5.
Vidlarova M, Berta E, Prasil P, Prokopova A, Gurska S, Khoylou M, et al.
Transl Lung Cancer Res
. 2022 Nov;
11(10):2040-2050.
PMID: 36386452
Background: Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related death with a 5-year survival of only 21%. Reliable prognostic and/or predictive biomarkers are needed to improve NSCLC...
6.
Spicka P, Chudacek J, rezac T, Stary L, Horacek R, Klos D
Life (Basel)
. 2022 Apr;
12(4).
PMID: 35454980
Introduction: Diffuse peritonitis is a serious disease. It is often addressed within urgent management of an unstable patient in shock. The therapy consists of treatment of the source of peritonitis,...
7.
Hlavacova L, Vrba R, Neoral C, Aujesky R, Stasek M, Chudacek J, et al.
Wideochir Inne Tech Maloinwazyjne
. 2021 Jun;
16(2):297-304.
PMID: 34136024
Introduction: The authors report long-term outcomes in patients who received neoadjuvant chemoradiotherapy and consequently underwent hybrid oesophagectomy for oesophageal cancer (OC). Aim: To evaluate long-term outcomes in patients suffering from...
8.
Konvicka P, Marek D, Habermann J, Jevik P, Chudacek J, ctvrtlik F, et al.
Vnitr Lek
. 2020 Sep;
66(2):53-57.
PMID: 32942888
Various types of tumors (either benign or malignant) can be found in mediastinum. Early diagnosis and treatment may help to improve survival and quality if life in these patients. Compared...
9.
Stasek M, Aujesky R, Vrba R, Lovecek M, Chudacek J, Janda P, et al.
Wideochir Inne Tech Maloinwazyjne
. 2018 Jul;
13(2):164-175.
PMID: 30002748
Introduction: Intraoperative esophagogastroduodenoscopy (IOG) is a diagnostic and therapeutic method for a variety of special conditions in upper gastrointestinal (UGI) pathology. The indication remains individual due to insufficient evidence and...
10.
Lovecek M, Skalicky P, Chudacek J, Szkorupa M, Svebisova H, Lemstrova R, et al.
World J Gastroenterol
. 2017 Nov;
23(35):6420-6428.
PMID: 29085191
Aim: To analyze pancreatic cancer patients who developed metachronous pulmonary metastases (MPM) as a first site of recurrence after the curative-intent surgery. Methods: One-hundred-fifty-nine consecutive pancreatic ductal adenocarcinoma (PDAC) patients...